Asymptomatic Bacteriuria

Asymptomatic Bacteriuria (ASB)

Asymptomatic bacteriuria (ASB) is defined as:

Presence of significant bacterial growth in urine in a patient WITHOUT signs or symptoms attributable to urinary tract infection (UTI).

Symptoms that must be absent include:

  • Dysuria
  • Frequency
  • Urgency
  • Suprapubic pain
  • Flank pain
  • Fever attributable to UTI
  • Costovertebral angle tenderness

Diagnostic Criteria

Standard Definition (IDSA 2019)

In Women (clean-catch specimen)

Two consecutive voided urine specimens preferably within 2 weeks with:

  • Same bacterial species
  • Quantitative count:≥10CFU/mL

AND:No urinary symptoms


In Men

Single clean-catch urine specimen with:≥105 CFU/mL

of a single organism.


Catheterized Specimen

  • Organisms present in lower quantitative counts likely represent contamination of the urine specimen from organisms present in the biofilm along the device rather than true bacteriuria and, in these patients, ≥105 CFU/mL remains the most appropriate diagnostic criteria for bladder bacteriuria.
  • Lower quantitative counts (≥102 to <105 CFU/mL) isolated from urine specimens collected by “in and out” catheterization or following insertion of a new indwelling catheter suggest true bacteriuria, but the clinical significance of these lower quantitative counts in people without symptoms has not been evaluated.
  • For women or men, a single specimen with isolation of one bacteria species with at least 100 CFUs per ml of urine.(preferred)

Important Principle

Pyuria ≠ UTI

Presence of:

  • WBCs in urine
  • Positive leukocyte esterase
  • Nitrites

DOES NOT diagnose symptomatic infection.

Pyuria is extremely common in:

  • Elderly
  • Catheterized patients
  • Diabetics
  • CKD
  • Neurogenic bladder

Pathophysiology

ASB occurs when:

  • Bacteria colonize urinary tract
  • Host immune response remains limited
  • No tissue invasion occurs

Some organisms may form:

  • Biofilms
  • Low-virulence colonization

Many ASB strains are actually less virulent than strains causing pyelonephritis.


Common Organisms

Most Common

Gram-negative

  • Escherichia coli (most common)
  • Klebsiella
  • Proteus
  • Enterobacter
  • Pseudomonas

Gram-positive

  • Enterococcus
  • Coagulase-negative staphylococci
  • Group B streptococcus

Risk Factors

Urinary Factors

  • Catheterization
  • Urinary obstruction
  • Vesicoureteral reflux
  • Neurogenic bladder
  • Urinary stasis
  • Stones

Host Factors

  • Female sex
  • Pregnancy
  • Diabetes
  • Advanced age
  • Immunosuppression

Institutional Factors

  • Nursing home residence
  • Frequent antibiotics
  • Repeated instrumentation

Clinical Features

NO urinary symptoms

Patient may have:

  • Positive urine culture
  • Pyuria(asymptomatic Pyuria)
  • Cloudy urine
  • Foul-smelling urine

But these ALONE do not indicate symptomatic UTI.


Differentials

1. Symptomatic UTI

Symptoms present:

  • Dysuria
  • Fever
  • Frequency
  • Flank pain

2. Contamination

Mixed flora,Low colony counts

3. Sterile Pyuria

Pyuria without bacterial growth.

Causes:

  • TB
  • STI
  • Interstitial nephritis
  • Stones
  • Partially treated UTI

Avoid Unnecessary Testing

Do NOT routinely send urine cultures in:

  • Elderly without symptoms
  • Delirium alone
  • Falls alone
  • Cloudy urine alone

Because this leads to overtreatment.


Who SHOULD Be Screened and Treated?

1. Pregnancy (VERY IMPORTANT)

ASB in pregnancy is associated with:

  • Pyelonephritis
  • Preterm labor
  • Low birth weight
  • Maternal sepsis

Screening Recommendation

Screen:Once early in pregnancy

  • Usually 12–16 weeks or first prenatal visit using urine culture.end of the first trimester of pregnancy 

Treatment Duration

Usually:4–7 days depending on antibiotic.


Common Drugs

Drug

Dose

Nitrofurantoin

100 mg BD

Cephalexin

500 mg QID

Amoxicillin-clavulanate

625 mg TDS

Fosfomycin

3 g single dose

Avoid

  • Fluoroquinolones
  • Tetracyclines

Avoid TMP-SMX in:

  • First trimester (folate effects)
  • Near term (kernicterus risk)

2. Before Urologic Procedures with Mucosal Trauma

Examples:

  • TURP
  • Endoscopic stone surgery
  • Ureteroscopy with manipulation

Why treat?

To prevent:Bacteremia/Urosepsis


Management

  • Obtain urine culture before procedure
  • Give targeted antibiotics
  • Short course sufficient

3. Early Renal Transplant (Selected Cases)

Some centers treat within:First 1–2 months post-transplantEvidence remains mixed.


Why Overtreatment Is Dangerous

Major Harm

1. Antimicrobial Resistance

Most important consequence.


2. Clostridioides difficile Infection

Antibiotics increase risk.


3. Adverse Drug Effects

  • AKI
  • Allergy
  • QT prolongation
  • Drug interactions

4. Microbiome Disruption


Catheter-Associated ASB (CA-ASB)

Long-term catheter:Nearly universal bacteriuria.


Important Principle

Do NOT culture urine routinely in catheterized patients without symptoms.


Symptoms Suggesting True CAUTI in communicative patient

  • Fever
  • Flank pain
  • Pelvic discomfort
  • Hemodynamic instability
  • New delirium WITH systemic signs

What do IDSA and CDC emphasize In a catheterized ICU patient:Non-communicative patient

Urine culture should be obtained when:

  1. Patient has fever or sepsis with no obvious source.
  2. New hemodynamic instability is present.
  3. Urinary tract source is clinically suspected.
  4. Catheter is replaced before obtaining urine sample (preferred).

References

  1. Givler DN, Givler A. Asymptomatic Bacteriuria. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441848/
  2. Clinical Infectious Diseases, Volume 68, Issue 10, 15 May 2019, Pages e83–e110, https://doi.org/10.1093/cid/ciy1121


Leave a Comment

Your email address will not be published. Required fields are marked *